您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:希玛眼科年度报告 2023 - 发现报告

希玛眼科年度报告 2023

2024-04-22港股财报L***
希玛眼科年度报告 2023

2023ANNUAL REPORT年度報告 2Corporate information4Financial highlights5Chairman’s statement11Management discussion and analysis34Profile of directors, senior management and company secretary43Report of the directors83Corporate governance report101Independent auditor’s report111Consolidated statement of comprehensive income113Consolidated statement of financial position115Consolidated statement of changes in equity116Consolidated statement of cash flows117Notes to the consolidated financial statements248Financial information summary Corporate Information公司資料 BOARD OF DIRECTORS Executive Directors 202373 Dr. LAM Shun Chiu Dennis(Chairman and Chief Executive Officer)Ms. LI XiaotingDr. LEE Yau Wing VincentMr. LI Chunshan (stepped down with effect from 3 July 2023) Independent Non-executive Directors 202353020235302023530202373 Dr. Rex AUYEUNG Pak-kuen(Vice Chairman)Dr. LI Kwok Tung Donald (retired on 30 May 2023)Mr. MA Andrew Chiu CheungMr. CHAN Chi Leong (retired on 30 May 2023)Ms. BENTLEY Annie Liang (retired on 30 May 2023)Mr. IP Shu Kwan StephenMr. YIN Ke (appointed with effect from 3 July 2023) BOARD COMMITTEES Audit Committee Mr. MA Andrew Chiu Cheung(Chairperson)Mr. IP Shu Kwan StephenMr. YIN Ke Remuneration Committee Mr. IP Shu Kwan Stephen(Chairperson)Ms. LI XiaotingMr. MA Andrew Chiu Cheung Nomination Committee Dr. Rex AUYEUNG Pak-kuen(Chairperson)Mr. MA Andrew Chiu CheungMr. YIN Ke AUTHORIZED REPRESENTATIVES Ms. LI XiaotingMr. CHAN Wa Ping COMPANY SECRETARYMr. CHAN Wa Ping AUDITOR 22 PricewaterhouseCoopersCertified Public AccountantsRegistered Public Interest Entity Auditor22/F, Prince’s BuildingCentralHong Kong REGISTERED OFFICE Cricket Square, Hutchins DriveP.O. Box 2681 Grand CaymanKY1-1111Cayman Islands Cricket Square, Hutchins DriveP.O. Box 2681 Grand CaymanKY1-1111Cayman Islands PRINCIPAL PLACE OF BUSINESS AND HEADOFFICE IN HONG KONG 1–31535 Suite 1535, Central Building1–3 Pedder StreetHong Kong PRINCIPAL SHARE REGISTRAR Conyers Trust Company (Cayman) LimitedCricket Square, Hutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman Islands Conyers Trust Company (Cayman) LimitedCricket Square, Hutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman Islands HONG KONG BRANCH SHARE REGISTRAR 183171712–1716 Computershare Hong Kong Investor Services LimitedShops 1712–1716, 17th FloorHopewell Centre183 Queen’s Road EastWanchaiHong Kong PRINCIPAL BANKERS The Bank of East Asia, LimitedBank of China (Hong Kong) LimitedBank of Communications Co., Ltd.Industrial and Commercial Bank of China LimitedThe Hongkong and Shanghai Banking Corporation Limited LEGAL ADVISOR ON HONG KONG LAWS 8126 Fangda Partners26th Floor, One Exchange Square8 Connaught PlaceCentral, Hong Kong www.cmereye.com COMPANY WEBSITEwww.cmereye.com STOCK CODE03309 03309 Financial Highlights財務概要 2023123120221231 The board (the “Board”) of directors (the “Directors”) ofC-MER Eye Care Holdings Limited (the “Company”) reports theannual consolidated results of the Company and its subsidiaries(collectively, the “Group”) for the year ended 31 December 2023,together with the comparative figures for the year ended 31December 2022. Note: 1 1This is not a measure of performance under Hong KongFinancial Reporting Standards (“HKFRS”), but is widely used bymanagement for monitoring business performance of a companyfrom operational perspective. It may not be comparable to similarmeasures presented by other companies. STRIVING TO CAPITALISE ON NEWOPPORTUNITIES ARISING FROM MEDICALSERVICES INTEGRATION BETWEEN HONGKONG AND MAINLAND THROUGH SUCCESSFULIMPLEMENTATION OF OUR “BRIGHT EYES &SHINY TEETH” DEVELOPMENT STRATEGY 20231231 On behalf of the Board, I hereby present to the shareholders ofthe Company the annual report of the Group for the year ended31 December 2023. 20231932.9%14.315.7%2820233.847208%90%4.281202427 2023 was a fruitful year for the Group in multiple facets. Withoperations fully resumed after the pandemic, the Group’s businessrapidly regained its momentum and grew beyond the pre-pandemic level, with revenue from core medical service increasedby 32.9% year-on-year to HK$1.9 billion, a record high sincethe listing. Our ophthalmic business grew steadily and achieveda record high revenue of HK$1.43 billion, representing a year-on-year growth of 15.7%, which further cemented its leadingposition among the ophthalmic service providers in Shenzhenand Hong Kong. The Group’s Shenzhen C-MER Aikangjian DentalGroup Co., Ltd. (“Shenzhen CKJ”), which has been servingHong Kong residents for over 28 years, rebounded stronglyfollowing the end of the pandemic, with revenue surging toHK$384.7 million in 2023, representing a year-on-year growthof 208%. Contributing almost 90% of the Group’s revenue fromdental services of HK$428.1 million, Shenzhen CKJ has alreadybecome a major source of our revenue. In February 2024, underthe recommendation of the Shenzhen Municipal Government,Shenzhen CKJ became the only specialised de